Randomised controlled monotherapy trials: Which comparators to use?

Epileptic Disorders

Volumn 14, Issue 3, 2012, Pages 235-241

  Beghi, Ettore ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Antiepileptic drugs; Clinical trial; Epilepsy; Monotherapy

Indexed keywords

CARBAMAZEPINE; ETHOSUXIMIDE; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PREGABALIN; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; ANTICONVULSIVE AGENT;

ATAXIA; BEHAVIOR DISORDER; CONFERENCE PAPER; DEPRESSION; DIGESTIVE SYSTEM DISEASE; DROWSINESS; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG ERUPTION; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EPILEPSY; FATIGUE; FOCAL EPILEPSY; HEADACHE; HUMAN; INSOMNIA; MEMORY DISORDER; MENTAL DISEASE; MONOTHERAPY; NEUROLOGIC DISEASE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TERATOGENICITY; TONIC CLONIC SEIZURE; TREATMENT OUTCOME; VERTIGO; EPILEPSIES, PARTIAL; SEIZURES;

ANTICONVULSANTS; CARBAMAZEPINE; EPILEPSIES, PARTIAL; EPILEPSY; HUMANS; SEIZURES; VALPROIC ACID;

EID: 84867430956     PISSN: 12949361     EISSN: 19506945     Source Type: Journal    
DOI: 10.1684/epd.2012.0531     Document Type: Conference Paper

References (29)

1. Beghi E, Beghi M, Cornaggia CM. The use of recently approved antiepileptic drugs: use with caution, use in refractory patients or use as first-line indications? Expert RevNeurother 2011; 11: 1759-67.
2. Bonnett L, Smith CT, Smith D, Williamson P, Chadwick D, Marson AG. Prognostic factors for time to treatment failure and time to 12 months of remission for patients with focal epilepsy: post-hoc, subgroup analyses of data from the SANAD trial. Lancet Neurol 2012; 4: 331-40.
3. Brodie MJ, Richens A, Yuen AW. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group. Lancet 1995; 345: 476-9.
4. Brodie MJ, Overstall PW, Giorgi L. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group. EpilepsyRes 1999; 37: 81-7. (Pubitemid 29413167)
5. Brodie MJ, Chadwick DW, Anhut H, et al. Gabapentin versuslamotrigine monotherapy: a double-blind comparison in newly diagnosed epilepsy. Epilepsia 2002; 43: 993-1000. (Pubitemid 35006474)
6. Brodie MJ, Perucca E, Ryvlin P, Ben-Menachem E, Meencke HJ. Levetiracetam Monotherapy Study Group. Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy. Neurology 2007; 68: 402-8. (Pubitemid 46208740)
7. Chadwick D. Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: a multicentre randomised double-blind study. Vigabatrin European Monotherapy Study Group. Lancet 1999; 354: 13-9. (Pubitemid 29304296)
8. Dogan EA, Usta BE, Bilgen R, Senol Y, Aktekin B. Efficacy, tolerability, and side effects of oxcarbazepine monotherapy: a prospective study in adult and elderly patients with newly diagnosed partial epilepsy. Epilepsy Behav 2008; 13: 156-61.
9. French JA. First-choice drug for newly diagnosed epilepsy. Lancet 2007; 369: 570-1.
10. French JA, Kanner AM, Bautista J, et al. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy. Neurology 2004; 62: 1252-60.
11. Gamble C, Williamson PR, Chadwick DW, Marson AG. A meta-analysis of individual patient responses to lamotrigine or carbamazepine monotherapy. Neurology 2006; 66: 1310-7. (Pubitemid 43739636)
12. Glauser T, Ben-Menachem E, Bourgeois B, et al. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 2006; 47: 1094-120. (Pubitemid 44086745)
13. Glauser TA, Cnaan A, Shinnar S, et al. Childhood Absence Epilepsy Study Group. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy. N Engl J Med2010; 362: 790-9.
14. Harden CL, Meador KJ, Pennell PB, et al. American Academy of Neurology; American Epilepsy Society. Management issues for women with epilepsy- focus on pregnancy (an evidence-based review): II. Teratogenesis and perinatal outcomes: Report of the Quality Standards Subcommittee and Therapeutics and Technology Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Epilepsia 2009; 50: 1237-46.
15. Johannessen SI, Landmark CJ. Antiepileptic drug interactions. Principles and clinical implications. Curr Neuropharmacol2010; 8: 254-67.
16. Kwan P, Brodie MJ. Effectiveness of first antiepileptic drug. Epilepsia 2001; 42: 1255-60. (Pubitemid 33070664)
17. Kwan P, Brodie MJ, Kalviainen R, Yurkewicz L, Weaver J, Knapp LE. Efficacy and safety of pregabalin versus lamotrigine in patients with newly diagnosed partial seizures: a phase 3, double-blind, randomized, parallel-group trial. Lancet Neurol2011; 10: 881-90.
18. Marson AG, Al-Kharusi AM, Alwaidh M, et al. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet2007a; 369: 1000-15. (Pubitemid 46436124)
19. Marson AG, Al-Kharusi AM, Alwaidh M, et al. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet2007b; 369: 1016-26. (Pubitemid 46436125)
20. National Institute for Clinical Excellence. Clinical guideline20, the epilepsies: the diagnosis and managementof the epilepsies in adults and children in primary andsecondary care. October 2004. http://www.nice.org.uk/nicemedia/ live/10954/29532.pdf.
21. Nieto-Barrera M, Brozmanova M, Capovilla G, et al. Lamictal vs Carbamazepine Study Group. A comparison of monotherapy with lamotrigine or carbamazepine in patients with newly diagnosed partial epilepsy. Epilepsy Res2001; 46: 145-55. (Pubitemid 32709928)
22. Panayiotopoulos CP. Evidence-based epileptology, randomized controlled trials, and SANAD: a critical clinical view. Epilepsia 2007; 48: 1268-74. (Pubitemid 47063095)
23. Perucca E, Tomson T. The pharmacological treatment of epilepsy in adults. Lancet Neurol 2011; 10: 446-56.
24. Privitera MD, Brodie MJ, Mattson RH, et al. Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy. Acta Neurol Scand2003; 107: 165-75. (Pubitemid 36398991)
25. Reunanen M, Dam M, Yuen AW. A randomised open multicentre comparative trial of lamotrigine and carbamazepine as monotherapy in patients with newly diagnosed or recurrent epilepsy. Epilepsy Res 1996; 23: 149-55. (Pubitemid 26124783)
26. Saetre E, Perucca E, Isojärvi J, Gjerstad L, & LAM 40089 Study Group. An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly. Epilepsia 2007; 48: 1292-302.
27. Scottish Intercollegiate Guidelines Network. Diagnosisand management of epilepsy in adults. A national clinicalguideline. April 2003, updated October 20, 2005. http://www.sign.ac.uk/pdf/sign70.pdf.
28. Stein MA, Kanner AM. Management of newly diagnosed epilepsy: a practical guide to monotherapy. Drugs2009; 69: 199-222.
29. Tomson T, Battino D, Bonizzoni E, et al. EURAP Study Group. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol 2011; 10: 609-17.